From DNA Damage to Nucleic Acid Sensing : A Strategy to Enhance Radiation Therapy
Cet article passe en revue les études récentes montrant que les effets antitumoraux des rayonnements ionisants dépendent des réponses immunitaires innée et adaptative, puis analyse comment améliorer efficacité de la radiothérapie en ciblant les mécanismes immunitaires impliqués dans la détection des acides nucléiques endommagés
Local irradiation (IR) is widely used in the treatment of primary and metastatic tumors. However, the impact of IR on the immune response is currently being defined. Local and distant relapse after radiotherapy often occurs. The current rationale for the use of IR is based on direct cytotoxicity to cancer cells; however, recent studies have shown that reduction of tumor burden following ablative (large dose) IR largely depends on type I interferon signaling and CD8+ T cell response. Here, we review recent findings indicating that antitumor effects of radiation are contributed by both innate and adaptive immune responses. We will focus on immune mechanisms, including cytosolic DNA sensing pathways that bridge the traditional view of IR-mediated DNA damage to DNA-sensing immune pathways. Also, we will discuss how the efficacy of radiation therapy might be enhanced by targeting nucleic acid-sensing pathways. These findings highlight the mechanisms governing tumor escape from the immune response and the therapeutic potential of synergistic strategies to improve the efficacy of radiotherapy via immunotherapeutic intervention.